PUBLISHER: Renub Research | PRODUCT CODE: 1246765
PUBLISHER: Renub Research | PRODUCT CODE: 1246765
Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis
Germany Diabetes Market is expected to be USD 30.4 Billion in 2028, registering a CAGR of 5.92% during the forecast period, 2023-2028, according to Renub Research. Germany has one of the highest diabetes in the European region. The number of type 2 diabetes people will continue to increase over the next twenty years. The German Diabetes Centre (DDZ) estimates that up to 12 Million people might suffer from metabolic disorders in 2040. The substantial increase in incidence not only of type 2 diabetes in the aging population but also of type 1 diabetes will present significant challenges to the German health system in the coming years. Currently, mortality rates among people with diabetes in Germany are about twice as high as those without diabetes.
Leading manufacturers focuses on technological innovations and developing advanced products to gain a substantial market share. There has been a significant rise in insulin delivery systems technology, ranging from insulin injections to insulin pumps. Technological innovations and advancements offer many conveniences in maintaining blood glucose levels. Therefore, owing to the increasing diabetes prevalence, the German diabetes market is anticipated to witness growth over the upcoming years. As a result Germany Diabetes Market was valued at US$ 21.51 Billion in 2022.
Number of Older Adults with Type 2 Diabetes is Increasing Particularly Rapidly
Diabetes is a major health problem and one of the massive challenges for German healthcare systems. The prevalence of 1 & 2 type diabetes in the German adult population is very high, along with an increasing number of undiagnosed patients. Factors to an unhealthy lifestyle and an aging population, the prevalence of type 2 diabetes are expected to increase more over the upcoming years. High-quality care, including adequate monitoring, active self-management, and control of risk factors, is critical for preventing complications of type 2 diabetes in German patients.
Furthermore, the rate of newly diagnosed Type 1 and 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care drugs.
Insulin Pen will create more demand in Germany
Germany Diabetic market is segmented into four parts; Insulin Pen, Continuous Glucose Monitoring (CGM) Device, Self Monitoring Blood Glucose (SMBG) Device, and Insulin Pump. All four insulin delivery devices segment mentioned above are growing year on year. Insulin pen will hold significant market demand in upcoming years. Insulin pens are gaining popularity due to their unique features, such as easy to carry, user-friendly design, and ease of usage. With the rising incidences of diabetic problems, various digital care solutions have been introduced to help people with diabetes.
In recent years, Germany has witnessed an alarming increase in the prevalence of diabetes. Patients with diabetes require many daily corrections to maintain nominal blood glucose levels, such as SMBG and CGM, by monitoring their blood glucose levels. Over the past decade, the utilization of diabetes technology, such as insulin pumps and continuous glucose monitors (CGMs), for the management of pediatric type 1 diabetes has increased in Germany. For instance, In Oct 2022, Mediq, a comprehensive European, announced to acquisition DiaExpert, a diabetes specialist and mail-order company for diabetes supplies in Germany, currently part of the Ypsomed Group.
German Government Initiative
Germany diabetes pandemic emerged quickly enough to challenge health services and was gradually sufficient to give the impression that minor changes would be enough to cope with the rising burden. German law planned to cap out-of-pocket healthcare costs and to cover all medically necessary treatment, including insulin drugs, for the public. As a result, German diabetes patients have some of the lowest out-of-pocket expenses in the world.
Germany diabetes is a significant health problem and one of the astounding challenges for healthcare systems. The growing incidence, prevalence, and progressive nature of the disease have encouraged the development of new drugs to provide additional treatment options for diabetic patients. Many newly launched products, increasing awareness about diabetes among people, and increasing international research collaborations in technology advancement are the main opportunities for the players in the German diabetes drugs market.
Key Players
Some of the prominent market players are: B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic,Tandem Diabetes Care.
In April 2022, CamDiab, Abbott, and Ypsomed partnered to develop and market an integrated automated insulin delivery (AID) system, which helps to decrease the burden of people with diabetes. The main focus of this partnership will be on European countries.
In June 2022, Abbott announced that it was developing a new bio-wearable for continuously monitoring glucose and ketone levels in one sensor.
Renub Research report titled "Germany Diabetes Market, By Self-Monitoring Blood Glucose Device (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP) Companies (B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic and Tandem Diabetes Care)" provides a complete analysis of Germany Insulin Devices Market.
Segments Market based on Devices
- 1. Continuous Glucose Monitoring (CGM)
- 2. Self-Monitoring Blood Glucose (SMBG)
- 3. Insulin Pen
- 4. Insulin Pump
Germany Diabetes Sub-Segment Analysis
- 1. Continuous Glucose Monitoring (CGM)
- 1. Glucose Sensor Market & Forecast
- 2. CGM Transmitter Market & Forecast
- 3. CGM User
- 4. CGM Reimbursement
- 2. SMBG
- 1. Test Strips Market and Forecast
- 2. Lancet Market and Forecast
- 3. Meter Market and Forecast
- 4. Blood Glucose (SMBG) Users
- 5. Blood Glucose Devices Reimbursement
- 3. Insulin Pen Market
- 1. Disposable Insulin Pen
- 2. Reusable Insulin Pen
- 3. Smart Insulin Pen
- 4. Insulin Pen Needle Market
- 5. Insulin Pen Users
- 6. Reimbursement Policies
- 4. Insulin Pump Market
- 1. Insulin Pump Market
- 2. Insulin Pump Users
- 3. Insulin Pump Products
- 4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
- 1. B. Braun Melsungen AG
- 2. Eli Lilly, and Company
- 3. Terumo Corporation
- 4. Becton, Dickinson (BD)
- 5. Novo Nordisk
- 6. Ypsomed AG
- 7. Medtronic
- 8. Insulet Corporation
- 9. Abbott Laboratories
- 10. DarioHealth Crop
- 11. Dexcom, Inc
- 12. Roche Diagnostic
- 13. Tandem Diabetes Care
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Germany Diabetes Market
6. Germany Diabetes Population
- 6.1 Type 1 Diabetes Population
- 6.1 Type 2 Diabetes Population
7. Market Share -Germany Diabetes Market
- 7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Germany Market & Users
- 8.1 Germany- CGM Market by Components
- 8.1.1 Glucose Sensor Market & Forecast
- 8.1.2 CGM Transmitter Market & Forecast
- 8.2 Germany- CGM User
- 8.3 CGM Reimbursement in Germany
9. Blood Glucose Device (SMBG) - Germany Market & Users
- 9.1 SMBG Market
- 9.1.1 Type 1 Diabetes
- 9.1.2 Type 2 Diabetes
- 9.2 Test Strips Market and Forecast
- 9.2.1 Type 1 Diabetes
- 9.2.2 Type 2 Diabetes
- 9.3 Lancet Market and Forecast
- 9.3.1 Type 1 Diabetes
- 9.3.2 Type 2 Diabetes
- 9.4 Meter Market and Forecast
- 9.4.1 Type 1 Diabetes
- 9.4.2 Type 2 Diabetes
- 9.5 Blood Glucose Device (SMBG) Users
- 9.5.1 Type 1 Diabetes
- 9.5.2 Type 2 Diabetes
- 9.6 Reimbursement of Blood Glucose Devices in Germany
10. Insulin Pen - Germany Market & User Analysis
- 10.1 Insulin Pen Market
- 10.1.1 Disposable Insulin Pen Market
- 10.1.2 Reusable Insulin Pen Market
- 10.1.3 Smart Insulin Pen Market
- 10.2 Insulin Pen User
- 10.2.1 Disposable Insulin Pen User
- 10.2.2 Reusable Insulin Pen User
- 10.2.3 Smart Insulin Pen User
- 10.3 Insulin Pen Needle Market
- 10.4 Reimbursement Policies
11. Insulin Pump - Germany Market & User Analysis
- 11.1 Insulin Pump Market
- 11.1.1 Type 1
- 11.1.1 Type 2
- 11.2 Insulin Pump User
- 11.2.1 Type 1
- 11.2.1 Type 2
- 11.3 Differentiation Points of Insulin Pump Products in Germany
- 11.3.1 Animas Vibe
- 11.3.2 Medtronic 530G with Enlite
- 11.3.3 Insulet OmniPod
- 11.3.4 Tandem t: slim
- 11.3.5 Roche Accu-Chek Combo
- 11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
- 11.4.1 Medtronic
- 11.5 Insulet Corporation
- 11.5.1 Training Structure for New Patients - Insulet Corporation
- 11.6 Animas Corporation
- 11.6.1 Training Modules for New Patients
- 11.6.2 Training Modules for HCP (Health Care Professional)
- 11.7 Tandem Diabetes Care
- 11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen - Company Analysis
- 12.1 B. Braun Melsungen AG
- 12.1.1 Overview
- 12.1.2 Recent Developments
- 12.1.3 Revenue
- 12.2 Eli Lilly
- 12.2.1 Overview
- 12.2.2 Recent Developments
- 12.2.3 Revenue
- 12.3 Terumo Corporation
- 12.3.1 Overview
- 12.3.2 Initiatives & Recent Developments
- 12.3.3 Revenue
- 12.4 Becton, Dickinson (BD)
- 12.4.1 Overview
- 12.4.2 Recent Developments
- 12.4.3 Revenue
- 12.5 Novo Nordisk A/S
- 12.5.1 Overview
- 12.5.2 Initiatives & Recent Developments
- 12.5.3 Revenue
- 12.6 Ypsomed AG
- 12.6.1 Overview
- 12.6.2 Recent Developments
- 12.6.3 Revenue
13. Insulin Pump - Company Analysis
- 13.1 Medtronic
- 13.1.1 Overview
- 13.1.2 Recent Developments
- 13.1.3 Revenue
- 13.2 Insulet Corporation
- 13.2.1 Overview
- 13.2.2 Recent Developments
- 13.2.3 Revenue
14. SMBG - Company Analysis
- 14.1 DarioHealth Corp
- 14.1.1 Overview
- 14.1.2 Revenue
- 14.2 Abbott Laboratories
- 14.2.1 Overview
- 14.2.2 Revenue
15. CGM - Company Analysis
- 15.1 Dexcom Inc
- 15.1.1 Overview
- 15.1.2 Recent Developments
- 15.1.3 Revenue
- 15.2 Roche
- 15.2.1 Overview
- 15.2.2 Recent Developments
- 15.2.3 Revenue
- 15.3 Tandem Diabetes Care
- 15.3.1 Overview
- 15.3.2 Recent Developments
- 15.3.3 Revenue
List of Figures
- Figure-01: Germany - Diabetes Market (Billion US$), 2017 - 2022
- Figure-02: Germany - Forecast for Diabetes Market (Billion US$), 2023 - 2028
- Figure-03: Germany - Type 1 Diabetes Population (Thousand), 2017 - 2022
- Figure-04: Germany - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
- Figure-05: Germany - Type 2 Diabetes Population (Thousand), 2017 - 2022
- Figure-06: Germany - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
- Figure-07: Germany - Glucose Sensor Market Market (Million US$), 2017 - 2023
- Figure-08: Germany - Forecast for Glucose Sensor Market Market (Million US$), 2023 - 2028
- Figure-09: Germany - CGM Transmitter Market Market (Million US$), 2017 - 2023
- Figure-10: Germany - Forecast for CGM Transmitter Market Market (Million US$), 2023 - 2028
- Figure-11: Germany - CGM User (Thousand), 2017 - 2023
- Figure-12: Germany - Forecast for CGM User (Thousand),2023 - 2028
- Figure-13: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
- Figure-14: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
- Figure-15: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
- Figure-16: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
- Figure-17: Germany - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
- Figure-18: Germany - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
- Figure-19: Germany - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
- Figure-20: Germany - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
- Figure-21: Germany - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
- Figure-22: Germany - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
- Figure-23: Germany - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
- Figure-24: Germany - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
- Figure-25: Germany - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
- Figure-26: Germany - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
- Figure-27: Germany - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
- Figure-28: Germany - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
- Figure-29: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
- Figure-30: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
- Figure-31: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
- Figure-32: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
- Figure-33: Germany - Disposable Insulin Pen Market (Million US$), 2017 - 2023
- Figure-34: Germany - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
- Figure-35: Germany - Reusable Insulin Pen Market (Million US$), 2017 - 2023
- Figure-36: Germany - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
- Figure-37: Germany - Smart Insulin Pen Market (Million US$), 2017 - 2023
- Figure-38: Germany - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
- Figure-39: Germany - Disposable Insulin Pen User (Thousand), 2017 - 2022
- Figure-40: Germany - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
- Figure-41: Germany - Reusable Insulin Pen User (Thousand), 2017 - 2022
- Figure-42: Germany - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
- Figure-43: Germany - Smart Insulin Pen User (Thousand), 2017 - 2022
- Figure-44: Germany - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
- Figure-45: Germany - Insulin Pen Needle Market (Million US$), 2017 - 2023
- Figure-46: Germany - Forecast for Pen Needle Market (Million US$), 2023 - 2028
- Figure-47: Germany - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
- Figure-48: Germany - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
- Figure-49: Germany - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
- Figure-50: Germany - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
- Figure-51: Germany - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
- Figure-52: Germany - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
- Figure-53: Germany - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
- Figure-54: Germany - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
- Figure-55: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
- Figure-56: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-57: Eli Lilly - Global Revenue (Million US$), 2017 - 2022
- Figure-58: Eli Lilly - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-59: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
- Figure-60: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-61: BD - Global Revenue (Billion US$), 2017 - 2022
- Figure-62: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-63: Novo Nordisk A/S - Global Revenue (Million US$), 2017 - 2022
- Figure-64: Novo Nordisk A/S - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-65: Ypsomed AG - Global Revenue (Million US$), 2017 - 2022
- Figure-66: Ypsomed AG - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-67: Medtronic - Global Revenue (Billion US$), 2017 - 2022
- Figure-68: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-69: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
- Figure-70: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-71: DarioHealth Corp - Global Revenue (Million US$), 2017 - 2022
- Figure-72: DarioHealth Corp - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-73: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
- Figure-74: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-75: Dexcom Inc - Global Revenue (Million US$), 2017 - 2022
- Figure-76: Dexcom Inc - Forecast for Global Revenue (Million US$), 2023 - 2028
- Figure-77: Roche - Global Revenue (Billion US$), 2017 - 2022
- Figure-78: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
- Figure-79: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
- Figure-80: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables
- Table-01: Germany - Diabetes Market Share by Type (Percent), 2017 - 2022
- Table-02: Germany - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
